title: Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
abstract: Sequence-specific binding by the human p53 master regulator is critical to its tumor suppressor activity in response to environmental stresses. p53 binds as a tetramer to two decameric half-sites separated by 0-13 nucleotides (nt), originally defined by the consensus RRRCWWGYYY (n = 0-13) RRRCWWGYYY. To better understand the role of sequence, organization, and level of p53 on transactivation at target response elements (REs) by wild type (WT) and mutant p53, we deconstructed the functional p53 canonical consensus sequence using budding yeast and human cell systems. Contrary to early reports on binding in vitro, small increases in distance between decamer half-sites greatly reduces p53 transactivation, as demonstrated for the natural TIGER RE. This was confirmed with human cell extracts using a newly developed, semi-in vitro microsphere binding assay. These results contrast with the synergistic increase in transactivation from a pair of weak, full-site REs in the MDM2 promoter that are separated by an evolutionary conserved 17 bp spacer. Surprisingly, there can be substantial transactivation at noncanonical (1/2)-(a single decamer) and (3/4)-sites, some of which were originally classified as biologically relevant canonical consensus sequences including PIDD and Apaf-1. p53 family members p63 and p73 yielded similar results. Efficient transactivation from noncanonical elements requires tetrameric p53, and the presence of the carboxy terminal, non-specific DNA binding domain enhanced transactivation from noncanonical sequences. Our findings demonstrate that RE sequence, organization, and level of p53 can strongly impact p53-mediated transactivation, thereby changing the view of what constitutes a functional p53 target. Importantly, inclusion of (1/2)- and (3/4)-site REs greatly expands the p53 master regulatory network.
authors: Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, United States of America.
authors: Jennifer J
authors: JJ
authors: Jordan
authors: Daniel
authors: D
authors: Menendez
authors: Alberto
authors: A
authors: Inga
authors: Maher
authors: M
authors: Noureddine
authors: Maher
authors: M
authors: Nourredine
authors: Douglas A
authors: DA
authors: Bell
authors: Douglas
authors: D
authors: Bell
authors: Michael A
authors: MA
authors: Resnick
mesh_terms: D001483:Base Sequence; D001665:Binding Sites / Q000235:genetics; D001681:Biological Assay; D045744:Cell Line, Tumor; D016384:Consensus Sequence; D004247:DNA / Q000235:genetics / Q000378:metabolism*; D021901:DNA, Intergenic / Q000235:genetics; D019281:Dimerization; D004171:Diploidy; D017930:Genes, Reporter; D006801:Humans; D049410:Luciferases, Renilla / Q000032:analysis / Q000378:metabolism; D008969:Molecular Sequence Data; D017354:Point Mutation; D011401:Promoter Regions, Genetic; D017434:Protein Structure, Tertiary / Q000235:genetics; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics; D020218:Response Elements / Q000235:genetics; D012441:Saccharomyces cerevisiae / Q000235:genetics*; D015533:Transcriptional Activation; D014162:Transfection; D016159:Tumor Suppressor Protein p53 / Q000235:genetics* / Q000378:metabolism / Q000502:physiology
chemical_list: D021901:DNA, Intergenic; D016159:Tumor Suppressor Protein p53; D004247:DNA; D049410:Luciferases, Renilla; D051736:Proto-Oncogene Proteins c-mdm2